As the complexity of patient care increases, so does the prevalence of polypharmacy, defined as the concurrent use of multiple medications by a patient. This phenomenon, while sometimes necessary, poses significant challenges due to potential drug-drug interactions (DDIs).
With the aging population and the rise in chronic diseases, polypharmacy has become commonplace. It is particularly prevalent among the elderly, where it is associated with increased morbidity and mortality, decreased physical and cognitive functioning, and a higher risk of hospitalization.
DDIs occur when the effect of one drug is altered by another. They can lead to decreased therapeutic efficacy or increased toxicity. The risk of DDIs exponentially increases with each additional medication, making polypharmacy a significant concern.
Healthcare professionals can employ several strategies to manage polypharmacy effectively. Regular medication reviews are crucial, focusing on the appropriateness of each drug. Deprescribing, the systematic process of identifying and discontinuing drugs in instances where existing or potential harms outweigh benefits, is also an important tool.
Modern healthcare technology can assist in managing polypharmacy. Electronic health records (EHRs) and clinical decision support systems (CDSS) can flag potential DDIs, aiding clinicians in prescribing decisions. However, these tools' effectiveness depends on their correct and consistent use.
Navigating the complex landscape of polypharmacy and DDIs is a crucial aspect of modern healthcare. Through proactive strategies like regular medication reviews and deprescribing, along with the effective use of technology, healthcare professionals can mitigate the risks associated with polypharmacy, enhancing patient safety and outcomes.
1.
Discovery reveals protein involved in Parkinson's disease also drives skin cancer
2.
The prognosis of the Slovakian PM; Kate Middleton's treatment; and drug test cheating.
3.
We Don't Always Know What's 'Best' for Our Patients
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
Dual-action mRNA vaccine takes aim at aggressive skin cancer
1.
The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology
2.
Case Study: Combining Targeted Therapy with Immunotherapy for Metastatic Melanoma
3.
Anion Gap: The Simple Calculation That Reveals Much About Your Health
4.
Contemporary Methods in Hematology Across Clinical Settings
5.
Unlocking the Potential of Cytarabine: A New Era of Cancer Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
5.
Current Scenario of Cancer- Palliative Care to Close the Care Gap
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation